• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Roy S, Lagree S, Hou Z, Thomson JA, Stewart R, Gasch AP. Integrated module and gene-specific regulatory inference implicates upstream signaling networks. PLoS Comput Biol 2013;9:e1003252. [PMID: 24146602 PMCID: PMC3798279 DOI: 10.1371/journal.pcbi.1003252] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Accepted: 08/17/2013] [Indexed: 11/19/2022]  Open
2
Dean D, Atik B, Ton TKT, Vu QL, Lagree S. Evaluating the "A" component of the SAFE strategy. Lancet Infect Dis 2007;7:2-3. [PMID: 17182334 DOI: 10.1016/s1473-3099(06)70661-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
3
Lokiec F, Raymond E, Alexandre J, Brain E, Ould Kaci M, Lagree S, Smith S, Vanderbilt K, Cvitkovic E, Misset J. Pharmacokinetics (PK) of irofulven using two different intermittent dosing schedules as a 30 minute (MIN) infusion in advanced solid tumors (AST): Preliminary data. Eur J Cancer 2001. [DOI: 10.1016/s0959-8049(01)80732-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
4
Lokiec F, Alexandre J, Raymond E, Brain E, Ould Kaci M, Lagree S, Vignot S, Smith S, Cvitkovic E, Misset J. Pharmacokinetics (PK) of irofulven using three different intermittent 5-minutes (MIN) infusion dosing schedules (sch) in advanced solid tumors (AST): Final results. Eur J Cancer 2001. [DOI: 10.1016/s0959-8049(01)80727-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
5
Alexandre J, Chieze S, Raymond E, Brain E, Ould Kaci M, Smith S, Lagree S, Vanderbilt K, Cvitkovic E, Kahatt C. Phase I study of MGI 114 (irofulven) exploring 3 different iv schedules (SCH) as a 5 minute infusion in advanced solid tumors (AST): final results. Eur J Cancer 2001. [DOI: 10.1016/s0959-8049(01)80742-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA